Washington Homeopathic Products Homeopathic Medicine Fails Identity Testing
Washington Homeopathic Products is recalling La Core LCL-2-0191 Blend homeopathic medicine due to out-of-specification test results in identification testing. The product was distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving an out-of-specification test result in a homeopathic product. No illnesses, injuries, or deaths are reported in the source text. The hazard is a quality/identity specification failure rather than an acute safety threat, making this a precautionary recall.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling La Core LCL-2-0191 Blend, a homeopathic medicine product containing 149,980 mL bottles with 20% alcohol. The product was manufactured for further manufacturing use only and contains multiple homeopathic ingredients including Lycopodium Clavatum, Carbo Vegetabilis, Natrum Muriaticum, and others.
The recall was initiated due to out-of-specification test results obtained during identification testing based on HPTLC (high-performance thin-layer chromatography) analysis. This indicates the product did not meet the required specifications for identity verification.
The affected product is Lot # 27861 with expiration date 8/17/2026, and was distributed nationwide in the USA. Consumers who have received this product should cease use and contact the manufacturer for further instructions.
The recalled product
- Product
- La Core LCL-2-0191 Blend, 149,980ml 20% Alcohol, WHP Homeopathic Medicine, For Manufacturing Only, Liter LCL-2-0191-Bend: 12% Lycopodium Clavatum 10X, 12% Carbo Vegetabilis 16X, 12% Natrum Muriaticum 9X, 12% Calcarea Carbonica 12X, 10% Hypothalamus 30X, 6% Pituitarum Posterium 12
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic Medicine
- Hazard
- specification-failure
- identity-testing
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 27861
- Exp 8/17/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27